Kira Pharmaceuticals Gains NMPA and TGA Approvals for KP104 Phase II Study
Sino-US biotech Kira Pharmaceuticals has announced receiving approvals from China’s National Medical Products Administration (NMPA)...
TowardPi Raises RMB 300 Million in Series C Financing Round
China-based ophthalmology device maker TowardPi (Beijing) Medical Technology Ltd has reportedly raised close to RMB...
Aosaikang Receives FDA Approval for ASKG915 Clinical Trial
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced receiving clinical trial approval for its...
Pfizer Exercises Option for Sisunatovir Rights with LianBio
US major Pfizer Inc. (NYSE: PFE) has agreed with China-based LianBio (OTCMKTS: LIANY) to exercise...
Fosun Pharma Registers Comirnaty Vaccines in Hong Kong
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) has announced that Comirnaty (BNT162b2) and Comirnaty bivalent...
XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with the Experimental Drug...
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
Hong Kong-based Prenetics Global Ltd (NASDAQ: PRE) has announced the acquisition of a majority stake...
CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has announced that the Medicines and Healthcare products Regulatory Agency...
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
China-based Ascletis Pharma Inc. (HKG: 1672) has announced receiving the Notice of Issuance from the...
HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
Hutchison China Meditech (HutchMed; HKG: 0013, NASDAQ: HCM) has announced the initiation of a rolling...
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary Shandong Boan Biotechnology Co., Ltd has officially...
Simcere Pharmaceutical Completes Enrollment for SIM0417 COVID-19 Drug Trial
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the completion of enrollment of 1,208 patients...
Neurophth’s NFS-02 Gene Therapy Gets FDA IND Approval for LHON Treatment
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced obtaining Investigational New Drug (IND) approval...
TG ImmunoPharma Gains FDA Approval for Phase I Study of Anti-PVRIG Antibody
China-based TG ImmunoPharma Co., Ltd has announced receiving the go-ahead from the US FDA to...
Adagene Initiates International Study for ADG126 in Hepatocellular Carcinoma
China-based biotech Adagene Inc. (NASDAQ: ADAG), which also operates out of San Diego, California, has...
Jiangsu Recbio’s Herpes Zoster Vaccine REC610 Gets Clinical Trial Approval in Philippines
China-based vaccine maker Jiangsu Recbio Technology Co., Ltd (HKG: 2179) has announced receiving clinical trial...
Endo International Licenses TLC’s Phase III Nanomedicine for OA Knee Pain
Ireland-based Endo International plc (NASDAQ: ENDP) has announced a licensing deal between its subsidiary Endo...
GenFleet and Merck KGaA Partner on European Clinical Study for KRAS G12C Inhibitor
China-based GenFleet Therapeutics Inc. has announced a European multi-center clinical study and drug supply agreement...
Blue Sail Medical’s Microcatheter Receives NMPA Marketing Approval
China’s Blue Sail Medical Co., Ltd (SHE: 002382) has announced obtaining marketing approval from the...